[Panitumumab-induced trichomegaly]

Med Clin (Barc). 2013 Apr 20;140(8):e15. doi: 10.1016/j.medcli.2013.01.006. Epub 2013 Mar 11.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary
  • Adenocarcinoma / surgery
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / surgery
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / physiology
  • Eyelashes / drug effects*
  • Eyelashes / growth & development
  • Female
  • Fluorouracil / administration & dosage
  • Hair Diseases / chemically induced*
  • Humans
  • Leucovorin / administration & dosage
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Liver Neoplasms / surgery
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Proteins / antagonists & inhibitors
  • Panitumumab

Substances

  • Antibodies, Monoclonal
  • Neoplasm Proteins
  • Panitumumab
  • EGFR protein, human
  • ErbB Receptors
  • Leucovorin
  • Fluorouracil
  • Camptothecin

Supplementary concepts

  • IFL protocol